Zynerba Pharmaceuticals to Present at Two Upcoming Conferences
Zynerba Pharmaceuticals, Inc. is a leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders.
Read More
Select Page
Posted by Invest In Weed | Sep 3, 2019
Zynerba Pharmaceuticals, Inc. is a leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders.
Read MorePosted by Invest In Weed | Aug 29, 2019
MediPharm Labs specializes in the production of purified, pharmaceutical-like cannabis oil and concentrates and advanced derivative products.
Read MorePosted by Invest In Weed | Aug 29, 2019
The meeting is being held at Aston University in Birmingham, UK on September 4th through 6th, 2019.
Read MorePosted by Invest In Weed | Aug 15, 2019
The presentation is expected to cover the company’s strategic business activities, financial and operating performance, and outlook for the future.
Read MorePosted by Invest In Weed | Aug 9, 2019
The upcoming symposium, expertly designed for both farmers and entrepreneurs focuses on harvesting, processing and profit channels within the hemp industry.
Read MoreGet stock alerts, news & related alerts straight to your inbox!